The SARS-CoV-2 pandemic has had a significant impact worldwide. Currently, the most common detection methods for the virus are polymerase chain reaction (PCR) and lateral flow tests. PCR takes more than an hour to obtain the results and lateral flow tests have difficulty with detecting the virus at low concentrations. In this study, 60 clinical human saliva samples, which included 30 positive and 30 negative samples confirmed with RT-PCR, were screened for COVID-19 using disposable glucose biosensor strips and a reusable printed circuit board. The disposable strips were gold plated and functionalized to immobilize antibodies on the gold film. After functionalization, the strips were connected to the gate electrode of a metal-oxide-semiconductor field-effect transistor on the printed circuit board to amplify the test signals. A synchronous double-pulsed bias voltage was applied to the drain of the transistor and strips. The resulting change in drain waveforms was converted to digital readings. The RT-PCR-confirmed saliva samples were tested again using quantitative PCR (RT-qPCR) to determine cycling threshold (Ct) values. Ct values up to 45 refer to the number of amplification cycles needed to detect the presence of the virus. These PCR results were compared with digital readings from the sensor to better evaluate the sensor technology. The results indicate that the samples with a range of Ct values from 17.8 to 35 can be differentiated, which highlights the increased sensitivity of this sensor technology. This research exhibits the potential of this biosensor technology to be further developed into a cost-effective, point-of-care, and portable rapid detection method for SARS-CoV-2.

1.
Centers for Disease Control and Prevention
, Delta Variant: What We Know About the Science (
2021
).
2.
World Health Organization
, WHO Coronavirus (COVID-19) Dashboard (
2021
).
3.
B.
Udugama
 et al,
ACS Nano
14
,
3822
(
2020
).
4.
Centers for Disease Control and Prevention
, Covid-19 Testing: What You Need to Know (
2021
).
5.
S.
Pickering
 et al,
Lancet Microbe
2
,
e461
(
2021
).
6.
P.
Ranjan
,
A.
Singhal
,
S.
Yadav
,
N.
Kumar
,
S.
Murali
,
S. K.
Sanghi
, and
R.
Khan
,
Int. Rev. Immunol.
40
,
126
(
2021
).
7.
G.
Balkourani
,
A.
Brouzgou
,
M.
Archonti
,
N.
Papandrianos
,
S.
Song
, and
P.
Tsiakaras
,
J. Electroanal. Chem.
893
,
115289
(
2021
).
8.
T.
Chaibun
 et al,
Nat. Commun.
12
,
802
(
2021
).
9.
M. Z.
Rashed
,
J. A.
Kopechek
,
M. C.
Priddy
,
K. T.
Hamorsky
,
K. E.
Palmer
,
N.
Mittal
,
J.
Valdez
,
J.
Flynn
, and
S. J.
Williams
,
Biosens. Bioelectron.
171
,
112709
(
2021
).
11.
M. T.
Hwang
 et al,
Adv. Mater. Technol.
6
,
2100712
(
2021
).
12.
M.
Xian
 et al,
J. Vac. Sci. Technol. B
39
,
033202
(
2021
).
13.
A.
Tiwari
,
S.
Aryal
,
S.
Pilla
, and
S.
Gong
,
Talanta
78
,
1401
(
2009
).
14.
G. T.
Hermanson
, in
Bioconjugate Techniques
, 3rd ed., edited by
G. T.
Hermanson
(
Academic
,
Boston
,
2013
), pp.
229
258
.
15.
S. Y.
Lu
,
S. S.
Shan
,
J.
Yang
,
C. W.
Chang
,
F.
Ren
,
J.
Lin
,
S. J.
Pearton
, and
Y. T.
Liao
,
2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
, Berlin, Germany, 23–27 July 2019 (
IEEE, New York
,
2019
), pp.
5761
5764
.
16.
B. S.
Kang
,
F.
Ren
,
Y. W.
Heo
,
L. C.
Tien
,
D. P.
Norton
, and
S. J.
Pearton
,
Appl. Phys. Lett.
86
,
112105
(
2005
).
17.
Yale New Haven Hospital
, “Accelerated Emergency Use Authorization (EUA) Summary SARS-CoV-2 RT-PCR Assay,” FDA media No. 136602, Clinical Virology Laboratory, New Haven, CT (
2020
).
18.
S.
Daud
,
S.
Shahzad
,
M.
Shafique
,
M. A.
Bhinder
,
M.
Niaz
,
A.
Naeem
,
A.
Ali
,
Z.
Rahman
, and
T.
Husnain
,
Adv. Life Sci.
1
,
3
(
2014
).
You do not currently have access to this content.